1. Council decision 2005/387/JHA of 10 May 2005 on the information exchange, risk assessment and control of new psychoactive substances http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2005:127:0032:0037:EN:PDF
2. ACMD report on the major cannabinoid agonists. Consideration of the major cannabinoid agonists 12.09.09 http://drugs.homeoffice.gov.uk/publication-search/acmd/acmd-report-agonists2835.pdf?view=Binary
3. ACMD report on GBL & 1,4-BD: Assessment of Risk to the Individual and Communities in the UK. 06.08.09 http://drugs.homeoffice.gov.uk/publication-search/acmd/report-on-gbl12835.pdf?view=Binary
4. ACMD report on the control of 1-benzylpiperazine (BZP) and related compounds 21.05.09 http://drugs.homeoffice.gov.uk/publication-search/acmd/ACMD-BZP-Report2835.pdf?view=Binary
5. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003;Anderson;Ann Emerg Med,2006